freenet AG (LON:0MV2)
27.57
+0.58 (2.14%)
At close: Aug 8, 2025
Oncternal Therapeutics Market Cap
freenet AG has a market cap or net worth of 2.81 billion as of August 8, 2025. Its market cap has increased by 8.63% in one year.
Market Cap
2.81B
Enterprise Value
3.32B
Revenue
2.10B
Ranking
n/a
PE Ratio
14.13
Stock Price
$27.57
Market Cap Chart
Since December 10, 1999, freenet AG's market cap has increased from 953.62M to 2.81B, an increase of 194.23%. That is a compound annual growth rate of 4.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 2.81B | 3.34% |
Dec 30, 2024 | 2.72B | 3.84% |
Dec 29, 2023 | 2.61B | 21.41% |
Dec 30, 2022 | 2.15B | -8.05% |
Dec 30, 2021 | 2.34B | 20.51% |
Dec 30, 2020 | 1.94B | -13.02% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 169.80B |
HSBC Holdings | 161.85B |
Shell | 155.62B |
Unilever | 112.71B |
British American Tobacco p.l.c. | 91.53B |
Rolls-Royce Holdings | 90.57B |
Rio Tinto Group | 76.62B |
RELX PLC | 67.05B |